Anti-Nav1.6/SCN8A antibody
5
(4 Reviews)
|
(16 Publications)
Rabbit Polyclonal SCN8A antibody. Suitable for WB, IHC-FoFr, IHC-P, ICC/IF, IHC-Fr, IHC-FrFl and reacts with Mouse, Rat, Human samples. Cited in 16 publications.
View Alternative Names
MED, SCN8A, Sodium channel protein type 8 subunit alpha, Sodium channel protein type VIII subunit alpha, Voltage-gated sodium channel subunit alpha Nav1.6
- WB
CiteAb
Western blot - Anti-Nav1.6/SCN8A antibody (AB65166)
Western Blotting using Anti-Nav1.6/SCN8A antibody, ab65166. Publication image from Arechederra, M. et al., 2018, Nat Commun, 30089774. Legend direct from paper.
Downregulation of overexpressed genes with hypermethylated gene body CGI in Alb-R26Met HCC cells interferes with their tumorigenic properties both in vitro and in vivo. a Western blots showing SCN8A, ACTN1, SRD5A2, NFkB2 and NEURL1B protein levels in stable clones established after transfection of Alb-R26Met HCC14 cells with plasmids carrying a shRNA sequence targeting the corresponding gene. Protein levels were compared to control cells (ctr). ACTIN was used as a loading control in all western blots. The asterisk indicates nonspecific bands detected using anti-SRD5A2 antibodies. b–e Biological assays to assess functional properties of Alb-R26Met HCC14 cells carrying a shRNA sequence targeting candidate genes. Effects were compared to HCC14 cells either untransfected or transfected with a control shRNA (shCtrl). b Graph reporting the number of colonies formed in anchorage-independent growth assays using 2 different shRNA targeting sequences for each candidate gene. Note a decrease in colony number formation of cells with downregulated candidate genes compared with control cells. c Graphs reporting the number (left) and the size (right) of colonies formed in anchorage-dependent growth assays. Whereas no significant changes in colony numbers were detected, note a significant decrease in colony size when the candidate gene is downregulated. d Graph reporting number of spheres formed in tumour sphere assays. Note that downregulation of candidate genes significantly reduces sphere number formation. e Graph reporting the tumour volume of mice injected either with Alb-R26Met HCC14 control cells or with Alb-R26Met HCC14 cells carrying a shRNA sequence targeting candidate genes. Note that downregulation of candidate genes significantly interferes with the in vivo tumorigenic properties of Alb-R26Met HCC14 cells. Significant differences between groups are indicated on the top. *P < 0.05, **P < 0.01, ***P < 0.001 (nd : no determined)
false
Reactivity data
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Nav1.6 impacts neuronal excitability and firing by controlling sodium ion flow across the nerve cell membrane. It forms an integral part of the channel complex that ensures proper electrical signaling within neurons. It largely contributes to high-frequency firing and sustained repetitive firing of specific neurons which is essential for normal brain function. Alterations in Nav1.6 function can lead to abnormal electrical activity in the nervous system impacting overall neuronal communication.
Pathways
Nav1.6 participates significantly in the action potential propagation pathway. It plays a role alongside other sodium channels such as Nav1.1 and Nav1.2 to maintain the intricate balance of excitatory signals. Nav1.6 is also involved in signaling cascades that affect synaptic transmission and plasticity. In these pathways Nav1.6 interacts indirectly with various ion channels and proteins which collectively modulate neuronal excitability and plasticity important for processes like learning and memory.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (16)
Recent publications for all applications. Explore the full list and refine your search
World journal of gastrointestinal oncology 17:105264 PubMed40697228
2025
Applications
Unspecified application
Species
Unspecified reactive species
British journal of pharmacology 182:2542-2559 PubMed39965632
2025
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of clinical investigation 134: PubMed39088270
2024
Applications
Unspecified application
Species
Unspecified reactive species
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 10:e2205862 PubMed36922751
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in molecular neuroscience 15:822129 PubMed35557557
2022
Applications
Unspecified application
Species
Unspecified reactive species
Science advances 7: PubMed33741588
2021
Applications
Unspecified application
Species
Unspecified reactive species
Brain research bulletin 170:187-198 PubMed33610724
2021
Applications
Unspecified application
Species
Unspecified reactive species
Marine drugs 18: PubMed32471037
2020
Applications
Unspecified application
Species
Unspecified reactive species
Neural plasticity 2020:9132720 PubMed32256560
2020
Applications
Unspecified application
Species
Unspecified reactive species
Neuroscience 418:231-243 PubMed31473280
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com